ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
批准号:
3367605
负责人:
Parkash Singh Gill
金额:
$31.5万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1995-01-31
关键词:
AIDS DNA footprinting HIV infections Kaposi's sarcoma angiogenesis factor antineoplastics athymic mouse autocrine biological signal transduction cell growth regulation disease /disorder model epidermal growth factor fibroblast growth factor gender difference glucocorticoids growth factor hormone regulation /control mechanism human subject interleukin 6 mitogens molecular cloning molecular oncology molecular pathology northern blottings nucleic acid sequence phosphorylation polymerase chain reaction sex hormones tissue /cell culture transcription factor transfection transforming growth factors tumor necrosis factor beta vascular endothelium vascular endothelium permeability
中文摘要
卡波西肉瘤是一种肿瘤,其病变主要由
异常的血管增殖。肿瘤组织,或KS来源的纺锤体
当细胞被放置在裸鼠的皮下时,可以诱导血管
类似卡波西氏肉瘤的病变,起源于小鼠组织。
此外,病变显示血管延迟(12小时)。
高渗透反应。因此,这个肿瘤提供了一个很好的模型。
系统不仅对肿瘤本身有更多的了解,而且
参与血管生成的信号,并研究可以
后来被用来治疗各种疾病,包括血管
疾病、恶性肿瘤和炎症性疾病。
血管生成的主要介质包括:(I)成纤维细胞生长因子,
碱性和酸性,两者都缺乏信号肽,因此不是
分泌的,和(Ii)血管内皮细胞生长因子或血管
通透性因子(VDGF/VPF),具有信号肽,可分泌。
血管内皮生长因子/血管内皮生长因子和成纤维细胞生长因子由卡波西肉瘤来源的梭形细胞产生。
血管生成的二级介质(如肿瘤坏死因子、肿瘤坏死因子-α和β-干扰素、
血管生成素等)仅在体内诱导血管新生损伤。因此,这些
因素必须通过诱导原发来发挥它们的反应
调解人。KS来源的梭形细胞产生许多这样的细胞因子
(转化生长因子-β、IL-1和IL-6)。
此外,类固醇激素调节细胞因子的表达,进而
调节血管生成因子。或者,类固醇激素可以
直接调节血管生成因子。我们还表明,
糖皮质激素可过度增强IL-6的表达,进而
上调血管内皮生长因子/血管内皮生长因子。基于以上原因,我们建议研究
后续使用血管内皮细胞和血管平滑肌
作为控件的单元格:
(1)已知的血管生成主要介质在血管生成中的表达
KS来源的梭形细胞及其类固醇激素和激素的调节
细胞因子;(2)进一步定义小说的存在或不存在
KS来源的梭形细胞表达血管生成因子;(Iii)研究
IL-6和血管内皮细胞生长因子/血管内皮生长因子的信号转导途径;
糖皮质激素对KS细胞IL-6的反常上调作用
纺锤形细胞并与其他类型的细胞进行比较。
英文摘要
Kaposi's sarcoma is a tumor in which the lesion predominantly consists of
aberrant vascular proliferation. The tumor tissue, or KS-derived spindle
cells, when placed subcutaneously in the nude mouse, induces a vascular
lesion resembling Kaposi's sarcoma and is of mouse tissue origin.
Further, the lesion demonstrates a delayed (12 hr) vascular
hyperpermeability response. Thus, this tumor provides an excellent model
system to not only understand more about the tumor itself, but also the
signals involved in angiogenesis, and to study inhibitors that could
later be used for therapy of a variety of diseases, including vascular
diseases, malignancy and inflammatory disease.
Primary mediators of angiogenesis include: (i) fibroblast growth factors,
basic and acidic, both of which lack signal peptide and thus are not
secreted, and (ii) vascular endothelial cell growth factor or vascular
permeability factor (VDGF/VPF) which has signal peptide and is secreted.
VEGF/VPF and FGFs are produced by Kaposi's sarcoma derived spindle cells.
Secondary mediators of angiogenesis (such as TNF, TFG-alpha and beta,
angiogenin etc) induce angiogenic lesions only in vivo. Thus, these
factors must exert their response through the induction of primary
mediators. KS derived spindle cells produces many of these cytokines
(TGF-beta, IL-1 and IL-6).
Further, steroid hormones regulate cytokine expression which in turn
regulates angiogenic factors. Alternatively steroid hormones may
directly regulate angiogenic factors. We have also shown that
glucocorticoids pardoxically enhance IL-6 expression, which in turn
upregulates VEGF/VPF. Based on the above, we propose to study the
following using vascular endothelial cells and vascular smooth muscle
cells as controls:
(1) The expression of known primary mediators of angiogenesis in
KS-derived spindle cells and their regulation by steroid hormones and
cytokines; (ii) Define further the presence or absence of a novel
angiogenic factor expressed by KS-derived spindle cells; (iii) Study the
transduction pathway of IL-6 and VEGF/VPF; (iv) Define the mechanism of
the paradoxical upregulation of IL-6 with glucocorticoids in KS derived
spindle cells and compare to other cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)
-
批准号:6421160
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2000
-
负责人:Parkash Singh Gill
-
依托单位:
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
-
批准号:7371935
-
项目类别:
-
资助金额:$32.84万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA
-
批准号:6513187
-
项目类别:
-
资助金额:$31.77万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA
-
批准号:6376914
-
项目类别:
-
资助金额:$31.03万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
-
批准号:6893492
-
项目类别:
-
资助金额:$34.53万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA
-
批准号:6633260
-
项目类别:
-
资助金额:$32.58万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA
-
批准号:2873498
-
项目类别:
-
资助金额:$26.76万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
-
批准号:7067224
-
项目类别:
-
资助金额:$33.8万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA
-
批准号:6174393
-
项目类别:
-
资助金额:$30.4万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
-
批准号:7195712
-
项目类别:
-
资助金额:$32.84万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
-
批准号:7567592
-
项目类别:
-
资助金额:$32.84万
-
财政年份:1999
-
负责人:Parkash Singh Gill
-
依托单位:
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)
-
批准号:6263763
-
项目类别:
-
资助金额:$3.56万
-
财政年份:1998
-
负责人:Parkash Singh Gill
-
依托单位:
Translational and Clinical Sciences Research Program (Project-007)
-
批准号:8999055
-
项目类别:
-
资助金额:$2.66万
-
财政年份:1996
-
负责人:Parkash Singh Gill
-
依托单位:
ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
-
批准号:2224554
-
项目类别:
-
资助金额:$32.87万
-
财政年份:1992
-
负责人:Parkash Singh Gill
-
依托单位:
ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
-
批准号:3367604
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1992
-
负责人:Parkash Singh Gill
-
依托单位:
PATHOGENISIS OF KAPOSI'S SARCOMA
-
批准号:2094335
-
项目类别:
-
资助金额:$39.32万
-
财政年份:1989
-
负责人:Parkash Singh Gill
-
依托单位:
PATHOGENISIS OF KAPOSI'S SARCOMA
-
批准号:3196324
-
项目类别:
-
资助金额:$27.91万
-
财政年份:1989
-
负责人:Parkash Singh Gill
-
依托单位:
PATHOGENISIS OF KAPOSI'S SARCOMA
-
批准号:3196325
-
项目类别:
-
资助金额:$28.41万
-
财政年份:1989
-
负责人:Parkash Singh Gill
-
依托单位:
PATHOGENISIS OF KAPOSI'S SARCOMA
-
批准号:3196326
-
项目类别:
-
资助金额:$37.42万
-
财政年份:1989
-
负责人:Parkash Singh Gill
-
依托单位:
PATHOGENESIS OF KAPOSI'S SARCOMA
-
批准号:3196323
-
项目类别:
-
资助金额:$32.95万
-
财政年份:1989
-
负责人:Parkash Singh Gill
-
依托单位:
海外基金